Evaxion AS (EVAX)

4.13 -0.01 (-0.24%) USD  |  NASDAQ  |  Apr 16, 16:00
4.13 0.00 (0.00%) After-Hours: 20:00
More

Evaxion Research and Development Expense (Quarterly) : 2.558M for Dec. 31, 2025

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for EVAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Novo Nordisk A/S 2.283B
Ascendis Pharma A/S 88.09M
DBV Technologies SA 30.04M
Cellectis SA 19.62M
Akari Therapeutics Plc 1.084M